Finch Wins $25 Million From Ferring on Fecal-Transplant Patents

Ferring Pharmaceuticals Inc. must pay Finch Therapeutics Group Inc. and the University of Minnesota more than $25 million after a federal jury in Delaware found Ferring’s Rebyota infringes three patents for fecal-transplant technology.

Rebyota infringes Finch’s US Patent Nos. 10,675,309, 11,541,080 and US Patent No. 10,251,914, which the university licenses to Finch, according to a verdict issued Aug. 9 in the US District Court for the District of Delaware. Jurors awarded Finch and Minnesota damages including an upfront payment of $25 million and a royalty of $815,061.

The jury also found the infringement was intentional, which gives the ...